Curated News
By: NewsRamp Editorial Staff
October 07, 2026
SS Innovations Advances Telerobotic Surgery with 195 Remote Procedures
TLDR
- SS Innovations grows its SSi Mantra installed base 45% and pursues FDA and CE marking to lead telerobotic surgery.
- SSi Mantra performs remote surgeries by teleoperation, with 195 telesurgeries and 14,503 total procedures reported.
- Telerobotic surgery with SSi Mantra expands specialized care to 12 countries, improving access to cardiac procedures.
- SS Innovations has conducted 195 robotic telesurgeries, including long-distance heart operations, across 12 countries.
Impact - Why it Matters
The progress of telerobotic surgery, as demonstrated by SS Innovations' SSi Mantra system, has significant implications for the future of healthcare. By enabling remote procedures, this technology can bridge geographical barriers, allowing expert surgeons to perform complex operations on patients in underserved or distant locations. This could dramatically improve access to specialized surgical care, reduce travel burdens for patients, and enable timely interventions in emergency situations. Moreover, the expansion into 12 countries and pursuit of FDA and CE mark clearances signal a growing global acceptance and regulatory validation of telesurgery. As the technology matures, it may also drive down costs and increase efficiency in surgical workflows, ultimately benefiting patients, providers, and payers. For investors, SS Innovations' traction in this space positions it as a notable player in the expanding surgical robotics market.
Summary
The rapidly evolving field of telerobotic surgery is thrusting SS Innovations International (NASDAQ: SSII) and its founder and CEO, cardiac surgeon Dr. Sudhir Srivastava, into the spotlight. A recent MedTech Dive article, "Telerobotic surgery is advancing around the world. Will the US embrace it?", examined the technology's global progress and the regulatory and infrastructure challenges it faces. Dr. Srivastava told the publication that robotic surgery is inherently a form of teleoperation, and the key technical question is how much distance can be introduced without compromising responsiveness. The article highlighted SS Innovations alongside larger medical-device companies and emerging robotics developers (https://ibn.fm/4ZLvL).
SS Innovations is building a substantial track record with its SSi Mantra system. As of September 28, 2026, the company reported 195 robotic telesurgeries, including cardiac procedures and long-distance operations. The installed base reached 244 SSi Mantra systems, up 45% from the end of 2025, while cumulative procedures totaled 14,503. The system has expanded into 12 countries, with recent cardiac-surgery programs launched in Colombia and Sri Lanka and a new program established at HCG Hospital in Ahmedabad. SS Innovations is currently pursuing U.S. FDA clearance and European Union CE marking to further expand into international markets.
The company's advancements in telesurgery are part of a broader trend that could reshape access to surgical care. Read More>> For investors, the latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. MissionIR is a specialized communications platform that assists IR firms with syndicated content to enhance visibility of private and public companies. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN to millions of followers, and a full array of tailored corporate communications solutions. For more information, please visit www.MissionIR.com. Please see full terms of use and disclaimers on the MissionIR website: https://www.MissionIR.com/Disclaimer.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Advances Telerobotic Surgery with 195 Remote Procedures
